CGEN (Compugen Ltd.) Wutah pendapatan kuartal marang kuartal

Tandha merek Compugen Limited (CGEN)

Israel's geopolitical instability is impacting the trend of quarterly revenue growth on the GURU.Markets chart, where the 101.60 metric determines this level. Antibody development relies on predictive software for cancer target discovery, while the moderate capacity utilization of modern laboratories equipped with updated chromatography limits current production scale, creating specific constraints for the expansion of Compugen Ltd. (CGEN).

cgen.com (CGEN) - Owah-owahan pendapatan dibandhingake kuartal kepungkur saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Compugen Limited (CGEN)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis dhasar perusahaan:CGEN - Compugen Limited
Produk sing diprodhuksi Compugen Ltd

Quarterly revenue growth measures the dynamics of real sales, allowing investors to filter out market noise from the business's fundamental indicators. By analyzing the quarterly rate of revenue change, an investor can gauge the effectiveness of the company's commercial product execution. This metric is calculated by comparing current revenues with the same period from the previous year. For Compugen Ltd. (CGEN), this reflects the inflow of payments from pharma partners, which drive the development of the AI platform and provide R&D liquidity.

Perusahaan pesaing

IBRX - Wutah pendapatan kuartal marang kuartal|IMCR (immunocore.com) - Wutah dodolan kuartal marang kuartal|Janux Corp (JANX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Arcus Bio (RCUS)|Wutah dodolan triwulanan ZYME|TNGX - Owah-owahan pendapatan dibandhingake kuartal kepungkur|Wutah dodolan triwulanan IOVA (Iovance)|Owah-owahan dodolan kuartal marang kuartal IMTX|Wutah pendapatan triwulanan XNCR (Xencor)|Tambahing pendapatan triwulanan CMPX|replimune.com - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Lyell Pharma|Innate Pharma S.A. (IPHA) - Wutah pendapatan kuartal marang kuartal|Pyxis Oncology Inc. - Tambahing pendapatan triwulanan|IOBT (iobiotech.com) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Sutro Biopharma Inc.|Wutah pendapatan kuartal marang kuartal MiNK Therapeutics (INKT)|HOWL: Dinamika pendapatan kuartal marang kuartal|Immix Biopharma - Wutah dodolan triwulanan|ALX Oncology (ALXO) - Tingkat wutah pendapatan sajrone kuartal|CUE: Wutah dodolan triwulanan|Dinamika pendapatan kuartal marang kuartal PDSB|sonnetbio.com (SONN) - Wutah pendapatan kuartal marang kuartal|MAIA Biotechnology Inc (MAIA) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal liminatuspharma.com|Wutah pendapatan kuartal marang kuartal LVTX|Wutah dodolan triwulanan NXTC (NextCure, Inc.)|LPTX: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal intensitytherapeutics.com INTS|Sensei Bio (SNSE) - Tingkat wutah pendapatan sajrone kuartal|TOVX: Wutah dodolan triwulanan|Gritstone bio - Owah-owahan dodolan kuartal marang kuartal|Kineta Bio (KA) - Wutah pendapatan kuartal marang kuartal|NexImmune Inc (NEXI) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Turnstone Biologics Corp.|Wutah dodolan kuartal marang kuartal VCNX (Vaccinex, Inc.)|Wutah dodolan triwulanan HARP (Harpoon Tx)